Wednesday, July 22, 2026
ESMO pharmaceutical event banner
← Back to Events
Tier 1 Global Networking: High ONCOLOGY 93 DAYS AWAY

ESMO — 2026 — Madrid, Spain

Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncol

Madrid, Spain October 23 – October 27, 2026
All Events

Presentation data updated Jul 22, 2026, 2:31 AM UTC

Why This Event Matters

Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2026 from 23–27 October 2026 in Madrid, Spain, bringing together leading oncology

Industry impact

Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2.

Market implications

Expect signals on pricing, formulary strategy, and partnership economics in EU markets.

Regulatory implications

EMA and national HTA frameworks are frequently debated at industry gatherings.

Investor implications

Investors should track partnership announcements and pipeline signals from ESMO.

Competitive implications

Competitive positioning among oncology players is a core theme — compare with prior editions.

Event Significance

Tier-1 industry catalyst

30 /100 composite

ESMO is a targeted oncology forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.

  • Speaker quality 14/20

    Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.

  • Company participation 0/20

    Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.

  • Historical influence 10/20

    Some historical catalysts; compare readouts against last cycle.

  • Media coverage 6/20

    Niche coverage — subscribe for direct abstract alerts.

  • Pipeline relevance 0/20

    Early science or services-focused — lower near-term PDUFA linkage.

Key Takeaways

Key Themes

oncologyPipeline announcements

Key Markets

Europe

Key Opportunities

Partnership dealsLicensing discussionsVendor selection

Timeline & Milestones

  1. Pre-event intelligence Upcoming

    Abstract discovery in progress; monitor Key Data tab.

  2. Conference opens Oct 23, 2026 Upcoming

    Live readouts, late-breakers, and partnership announcements.

  3. Live coverage window Upcoming

    Nova editorial monitors confirmed data releases.

  4. Conference closes Oct 27, 2026 Upcoming

    Post-event recap, competitive takeaways, and trial updates.

Best for
BD teams Investors & analysts Regulatory leaders

Executive Summary

C-level brief

Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2

Primary audience: BD teams · Investors & analysts · Regulatory leaders

Analyst Watch

Investor desk

Investors should track partnership announcements and pipeline signals from ESMO.

Regulatory affairs

EMA and national HTA frameworks are frequently debated at industry gatherings.

Competitive intelligence

Competitive positioning among oncology players is a core theme — compare with prior editions.

vs. Prior Editions

Edition Presentations Companies
ESMO (current) 0 0
ESMO Gastrointestinal Cancers Congress (2026) 1 0
ESMO Preceptorship on Neuroendocrine (2026) 0 0

Competitive Landscape

Company map →

Competitive positioning among oncology players is a core theme — compare with prior editions.

Coverage & Analysis

No coverage articles yet. Check back closer to the event.

Related News & Research

Research hub →

Event Intelligence Summary

Standalone summaries for ESMO — optimized for research and AI retrieval.

Executive Summary

Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2

Analyst View

Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2

Investor View

Investors should track partnership announcements and pipeline signals from ESMO.

BD View

BD teams should prioritize partnership and licensing conversations at ESMO.

Key Facts

Event
ESMO
Focus
oncology
Region
Europe
Location
Madrid, Spain

Ask Nova AI

AI-assisted answers grounded in NovaPharmaNews intelligence

Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.

Frequently Asked Questions

What is ESMO?

ESMO is a oncology industry conference for executives, clinical leaders, and investors.

Who attends ESMO?

Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on oncology.

Why is ESMO important?

ESMO influences partnership timing and policy debates affecting oncology markets for the next 12–18 months.

Where is ESMO held?

ESMO is held in Madrid, Spain.

What should investors watch at ESMO?

Track partnership announcements, pipeline readouts, and management commentary on oncology catalysts.

What BD opportunities exist at ESMO?

BD teams use ESMO for licensing, co-development, and vendor selection across oncology.

How does ESMO compare with other pharma conferences?

ESMO is a tier-1 global congress for oncology — compare with peer events in the same vertical.

How do I get NovaPharmaNews coverage of ESMO?

Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.

Intelligence Navigation